LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer

Published:2018-10-01 Issue:12 Volume:9 Page:1725-1732
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Liu Yuechao¹,Xing Ying¹,Wang Hongmei²,Yan Shi¹,Wang Xinzhu¹,Cai Li¹^ORCID

Affiliation:

1. The Fourth Department of Medical Oncology; Harbin Medical University Cancer Hospital; Harbin China

2. Department of Pathology; Harbin Medical University Cancer Hospital; Harbin China

Funder

Scientific and technological innovation talents of Harbin

China Postdoctoral Science Foundation

Heilongjiang Postdoctoral Foundation, Hai Yan Youth fund

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12887/fullpdf

Reference36 articles.

1. HSP90 as a novel molecular target in non-small-cell lung cancer;Esfahani;Lung Cancer (Auckl),2016

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

3. Targeted therapy for localized non-small-cell lung cancer: A review;Paleiron;Onco Targets Ther,2016

4. Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma;Zhu;Oncotarget,2017

5. High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients;Sato;Cell Commun Signal,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the role of tumor microenvironment responsive nanobiomaterials in spatiotemporal controlled drug delivery for lung cancer therapy;Drug Delivery and Translational Research;2024-07-22

2. Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects;Pharmaceuticals;2022-05-18

3. LRH-1 high expression in the ovarian granulosa cells of PCOS patients;Endocrine;2021-06-15

4. LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer;Frontiers in Cell and Developmental Biology;2021-03-15

5. Another One Bites the Gut: Nuclear Receptor LRH-1 in Intestinal Regeneration and Cancer;Cancers;2021-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3